Guideline No. 422a: Menopause: Vasomotor Symptoms, Prescription Therapeutic Agents, Complementary and Alternative Medicine, Nutrition, and Lifestyle.
OBJECTIVE
Provide strategies for improving the care of perimenopausal and postmenopausal women based on the most recent published evidence.


TARGET POPULATION
Perimenopausal and postmenopausal women.


BENEFITS, HARMS, AND COSTS
Target population will benefit from the most recent published scientific evidence provided via the information from their health care provider. No harms or costs are involved with this information since women will have the opportunity to choose among the different therapeutic options for the management of the symptoms and morbidities associated with menopause, including the option to choose no treatment.


EVIDENCE
Databases consulted were PubMed, MEDLINE, and the Cochrane Library for the years 2002-2020, and MeSH search terms were specific for each topic developed through the 7 chapters.


VALIDATION METHODS
The authors rated the quality of evidence and strength of recommendations using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. See online Appendix A (Tables A1 for definitions and A2 for interpretations of strong and weak recommendations). INTENDED AUDIENCE: physicians, including gynaecologists, obstetricians, family physicians, internists, emergency medicine specialists; nurses, including registered nurses and nurse practitioners; pharmacists; medical trainees, including medical students, residents, fellows; and other providers of health care for the target population.


SUMMARY STATEMENTS
RECOMMENDATIONS.
['Yuksel|Nese|N|', 'Evaniuk|Debra|D|', 'Huang|Lina|L|', 'Malhotra|Unjali|U|', 'Blake|Jennifer|J|', 'Wolfman|Wendy|W|', 'Fortier|Michel|M|']
D000529:Complementary Therapies D005260:Female D006176:Gynecology D006801:Humans D008019:Life Style D008593:Menopause D055656:Prescriptions
menopause vasomotor symptoms management complementary therapy drug therapy hormone therapy